نتائج البحث

Eosinophilic Cells in Ovarian Borderline Serous Tumors as a Predictor of BRAF Mutation.

• Authors : Badlaeva, Alina¹ (AUTHOR) ; Tregubova, Anna¹ (AUTHOR) ; Palicelli, Andrea² (AUTHOR)

• Source: Cancers. Jul2024, Vol. 16 Issue 13, p2322. 14p.

تفاصيل العنوان

Survival of Patients With Primary Cutaneous Melanoma (Stages 0-IIА and IIB-IIC), Depending on the Presence of the BRAF Mutation in the Tumor and Surgical Treatment Option

• Authors : S. A. Yаrgunin; I. V. Reshetov; Ya. N. Shoykhet

Subjects: cutaneous melanoma; braf mutation; surgical treatment

• Source: Инновационная медицина Кубани, Vol 0, Iss 1, Pp 8-17 (2024)

تفاصيل العنوان

Testing the Addition of Nivolumab to Standard Treatment for Patients With Metastatic or Unresectable Colorectal Cancer That Have a BRAF Mutation

• Source: Randomized Phase II Trial of Encorafenib and Cetuximab With or Without Nivolumab (NSC #748726) for Patients With Previously Treated, Microsatellite Stable, BRAFV600E Metastatic and/or Unresectable

تفاصيل العنوان

Response to dabrafenib plus trametinib on a rare BRAF mutation (V600_W604 deletion–insertion R) in an advanced non‐small cell lung cancer patient

• Authors : Akiko Tamura; Ryoko Inaba Higashiyama; Tatsuya Yoshida

Subjects: BRAF mutation; BRAF V600_W604 deletion–insertion R; comprehensive genomic profiling

• Source: Thoracic Cancer, Vol 15, Iss 18, Pp 1454-1456 (2024)

تفاصيل العنوان

Osimertinib‐induced BRAF mutation in a single metastatic lesion among multiple pulmonary lesions in a case of lung cancer with EGFR exon 19 deletion.

• Authors : Miura, Hiroyuki¹ ; Miura, Jun²; Goto, Shinichi³

• Source: Respirology Case Reports. Aug2024, Vol. 12 Issue 8, p1-4. 4p.

تفاصيل العنوان

Compassionate Use Program to Access Trametinib and Dabrafenib for Patients With BRAF Mutation-positive Metastatic Melanoma

• Source: Managed Access Program (MAP) Cohort Treatment Plan CDRB436B2005CM to Provide Access to Trametinib and Dabrafenib for Patients With BRAF

تفاصيل العنوان

Assessing the Impact of Melanin Content on the Reliability of the Idylla™ BRAF Mutation Test.

• Authors : Parsons, Sam D.¹ ; Murphy, Kate²; Finall, Alison³

• Source: Journal of Molecular Pathology. Dec2023, Vol. 4 Issue 4, p307-317. 11p.

تفاصيل العنوان

Assessing the Impact of Melanin Content on the Reliability of the Idylla™ BRAF Mutation Test

• Authors : Sam D. Parsons; Kate Murphy; Alison Finall

Subjects: melanin content; Idylla™ BRAF Mutation Test; test reliability

• Source: Journal of Molecular Pathology, Vol 4, Iss 4, Pp 307-317 (2023)

تفاصيل العنوان

Efficacy of trametinib in a metastatic urothelial carcinoma patient with a BRAF mutation

• Authors : Hiroyuki Karasawa; Yota Yasumizu; Takeo Kosaka

Subjects: BRAF G469A; MEK inhibitor; patient‐proposed healthcare services

• Source: IJU Case Reports, Vol 7, Iss 5, Pp 375-378 (2024)

تفاصيل العنوان

Response to dabrafenib plus trametinib on a rare BRAF mutation (V600_W604 deletion–insertion R) in an advanced non‐small cell lung cancer patient.

• Authors : Tamura, Akiko¹ (AUTHOR); Inaba Higashiyama, Ryoko¹ (AUTHOR); Yoshida, Tatsuya¹ (AUTHOR)

• Source: Thoracic Cancer. Jun2024, Vol. 15 Issue 18, p1454-1456. 3p.

تفاصيل العنوان